Biotechnology is a field that has opened up new vistas for job seekers in
recent years. As the industry expands in terms of activities and numbers, there
is a long line of hopefuls waiting to enter this sunrise segment. Many students
pursuing their engineering courses in various disciplines are planning to opt
for biotechnology. It is important that they know what specific skills would be
required by the growing biotech industry.
The scientific and technical talent in engineering , process development,
manufacturing and rapidly developing clinical research capabilities in India is
recognized all over the world now. At the macro level this is fine. But
companies would be very happy to get people with the right skills who could
start straightaway with minimal internal training. And as many of the leading
biotech companies pursue expansion, a Big Bang effect in recruitment is expected
soon
"Success for Indian biotechnology will largely depend on creating the
lowest cost base for innovation, a strategy pursued by other nations including
China. India needs to differentiate itself through high-value innovation. It is
imperative to evolve fiscal and regulatory policies that alleviate capital
intensive research and manufacturing, long gestation timelines for product
commercialization and investments in patenting and technology licensing,"
said Kiran Mazumdar Shaw, chairman and managing director of Biocon India Ltd.
This big bang effect in biotech industry is not a sudden outcome. More
biotech-related jobs are available now than ever before, thanks to recent
industry dynamics. With many of the biotech pieces falling into place now, this
sector is all set to change the dynamics of material sciences, agriculture and
medicine.
Molecular chemistry, organic chemistry, botany and biology have been the
building blocks for biotech companies in the past. Now computer science is
nearly as important as other segments. Biotech companies are relying on computer
programmers more than ever before.
"The science of biotechnology together with the peripherals of this
sectors will sprout numerous job opportunities. The opportunities include
business development in contract research in the various segments of biotech,
financial management of biotechnology, legal issues related to intellectual
property rights , ethical issues and intellectual property rights," said
Villoo Morawala-Patell, founder and CEO, Avesthagen, Bangalore.
 |
What do companies look for specifically while recruiting people? Said S
Sowmyanarayan, assistant manager, Strand Genomics, "Requirement from an
individual is the ability to contribute either in life sciences or IT when
working in a team comprising of professionals from both fields. The basic
qualifications we look for are a master’s degree or a doctorate( Ph.D). There
are quite a few people getting trained in bioinformatics today. The posts
offered will depend on their qualification, experience, aptitude and ability.
The salaries are benchmarked against industry standards and would be comparable
with any other industry including IT."
"We are employing around 60 people in Avesthagen and get a very raw set
fresh from the academia. They need rigorous training to be reshaped to fit the
industrial bill. An international scientific advisory committee is with us,
which pulls us up every year on this score. Right now we have with us Dr David
Frisch from the US who is training our personnel on genome sequencing and
studies. Preferences are given to post-graduates and doctoral degree
holders," observed Morawala-Patell of Avesthagen.
Also, companies would like even scientists to have a better understanding of
the business processes and environment. Of course, interpersonal skills, the
ability and willingness to learn, to mould, to change are other things that
employers look for in potential candidates.
Companies feel that educational institutions could provide
the industry with candidates with more ready-to-use skill sets. The industry too
would like to work with the academia to make this happen.
"For best-trained manpower, the institutes and the
industry need to work together in developing better talent in this sector. The
sector is growing at an impressive rate and companies, which understand the ‘real
issues’ of the industry will only survive in the long run. Working with such
companies will result in overall development for professionals in this
sector." said Strand’s Sowmyanarayan.
Added Ocimum Biosolutions CEO Anuradha Acharya, "We need
good Masters and PhD level programs in biotech manufacturing. It could be in
conjunction with an existing department like chemical engineering and biotech
department. More training is needed for the people coming out fresh from
colleges."
Sartorius AG, a German based company has a lot of
expectations from its Indian wing. Especially so because the German major is
placing its bets on the Indian talent to provide it great results in
bio-manufacturing.
"The most important asset of any company today is
brainpower. Active knowledge management therefore is one of our primary tasks.
The challenge is to provide knowledge at the right time and place. The creative
and intellectual think tank in India can and shall drive growth for Sartorious
in Asia and the Sartorius Group as a whole." This are the words of Prof. Dr
Utz Claassen, Group CEO and chairman of the executive board, Sartorius AG.
There are companies like Ranbaxy Laboratories and Wockhardt,
which were primarily pharma companies, now investing heavily into biotech. Their
requirements are slightly different from the pureplay biotech players.
"There will be a demand for well-trained people in the
field and the hiring is expected to go up significantly in next few years. But
as such now the manpower available in this field is not adequately trained. We
will not take a chance, because we cannot afford to make any mistakes as we are
dealing with drugs and possibly recombinant drugs. We take people from IITs and
other regional colleges of excellence. We plan to employ about 20 to start off
and then progress slowly. Also the manpower available in this sector is not
adequately trained. We need to develop programs to increase innovation amongst
our students and there are only a handful of institutes to encourage that. The
truth is that most companies are looking for people who can do the job
efficiently and not just a person with a degree. However, a degree from a
reputed institute like IIT helps get across the resume filtering round."
said Dr Kulvinder Singh Saini, director- biotechnology and bioinformatics,
Ranbaxy.
He too recommends that students should be provided more
hands-on training in addition to the theoretical knowledge. As of now the thesis
projects for MSc and PhD are only "academic" in nature, with little
consideration about the industry expectations."
According to Habil Khorakiwala, chairman of Wockhardt,
"In our continuing thrust of developing leaders within a leading
organization, we have initiated a unique management program with the renowned
London College of Management. This three-year program makes it possible for our
field personnel to acquire a MBA degree specializing in sales and marketing from
the college. While the program brings the latest in the field of sales,
marketing and strategic planning to our sales force, it also enables them learn
from the best in the industry. Wockhardt also offers an attractive scholarship
linked to the work performance of the personnel. This is a major step in
creating our own virtual university - the Wockhardt Institute of Learning."
There is a strong demand for individuals with degrees in the
life sciences and computer sciences and multiple years of programming and
database development experience. Typical combinations include a PhD in molecular
biology, cell biology, or biochemistry and biosciences and in computer sciences.
Life science PhDs, largely self-taught in key computer skills with industry
experience have good opportunities. People who emerge from the few doctoral
programs in bioinformatics also will be "incredibly marketable",
especially those with industry experience.
Many Indian companies have introduced separate packages for
their biotech employees. They are looking for people who have skills in
-
Gene manipulation of microbes and animal cells.
-
Capacity in downstream processing and isolation
methods.
-
Skills in extraction and isolation of plants and
animals products.
-
Competence in recombinant DNA technology of plants
and animals.
Biocon, as a leading player in biotechnological solutions, is
seeking capable and focused individuals who can contribute significantly to its
growth. It is on the look out for professionals in manufacturing, quality
assurance, research & development and marketing in the areas of enzymology,
microbiology, biochemistry, biochemical engineering and pharmaceutical sciences.
Aurigene, a Bangalore based drug discovery company, creates
opportunities to enhance knowledge, provide the freedom to make mistakes and
take risks in driving the organization towards its goals. Teamwork and
multi-tasking across functions form the foundation of their philosophy. Aurigene
is looking for the talented individuals who relish teamwork and those who have a
passion for drug discovery, high integrity in research as well as daily life,
ability to experiment and innovate, keenness for collaborative work, desire to
be challenged and respect for individuals.
According to VV Raghavan, managing director of Lotus Labs, a
Bangalore- based contract research organization, " For the next three
years, I think drug discovery and molecular biology will be the hot areas in
biotech sector. As far as our company is considered we are into clinical trials
and are looking for the students who have completed MPharm, MBBS, MD and
MSc(analytical
chemistry)."
"The
catch here is, while the biotech sector is poised for a boom just as the IT
sector in the Nineties, it should not be over- hyped. There needs to be a focus
on fundamental issues: Are we funding the sector adequately? What are the
chances of original R&D and manufacture of biotech products? Are we again
going to breed a set of professionals whose career fortune will swell and ebb
with any slight change in the trends? Unless our efforts are directed at these
fundamental issues, career opportunities are bound to stagnate beyond a point
and India will not be able to join the biotech bandwagon," says MG Arun,
editor, Pharma Bio World.
It is also true that India has a large skilled workforce that
can work on research, manufacturing and sales of biological products, as well as
use its strengths in IT to analyse data (bioinformatics). Once there is more
clarity on the legal aspects of clinical trials, even that is a big opportunity.
There is absolutely no doubt that biotechnology is going to be a major
determining force in the discovery of new medicines and improved agricultural
productivity. With developments like the sequencing of the human genome, it is
not far off when we will have medicines that would strike at the root of
"hereditary" diseases like diabetes. Biopharmaceuticals are going to
play a big role in treatment of diseases in the future.
Roby Ajith
Page(s) 1 |